ICE inhibitor YVADcmk is a potent therapeutic agent against in vivo liver apoptosis

Current Biology

Volumn 6, Issue 9, 1996, Pages 1192-1195

  Rouquet, Nicolas ^a   Pagès, Jean Christophe ^a   Molina, Thierry ^b   Briand, Pascale ^a   Joulin, Virginie ^a  

^a INSTITUT COCHIN   (France)

^b Lab Univ Rech en Histopathologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

EID: 0030250572     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(02)70688-X     Document Type: Article

References (29)

1. Patel T, Gores GJ: Apoptosis and hepatobiliary disease. Hepatology 1995, 21:1725-1741.
2. Galle PR, Hofmann WJ, Walczak H, Schaller H, Otto G, Stremmel W, et al.: Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 1995, 182:1223-1230.
3. Ogasawara J, Watanabe FR, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, et al.: Lethal effect of the anti-Fas antibody in mice. Nature 1993, 364:806-809.
4. Leist M, Gantner F, Bohlinger I, Germann PG, Tiegs G, Wendel A: Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-α requires transcriptional arrest. J Immunol 1994, 153:1778-1788.
5. Leist M, Gantne, F, Jilg S, Wendel A: Activation of the 55 kDa receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J Immunol 1995, 154:1307-1316.
6. Leist M, Gantner F, Bohlinger I, Tiegs G, Germann PJ, Wendel A: Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Path 1995, 146:1220-1234.
7. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, et al.: A novel heterodimeric cysteine protease is required for interleukin-1 β processing in monocytes. Nature 1992, 356:768-774.
8. Beidler DR, Tewari M, Friesen PD, Poirier G, Dixit VM: The baculovirus p35 protein inhibits Fas- and tumor necrosis factor-induced apoptosis. J Biol Chem 1995, 270:16526-16528.
9. Tewari M, Dixit VM: Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus gene product. J Biol Chem 1995, 270:3255-3260.
10. Los M, Van de Craen M, Penning LC, Schenk H, Westendorp M, Baeuerle PA, et al.: Requirement of an ICE/ ced-3 protease for Fas/ APO-1-mediated apoptosis. Nature 1995, 375:81-83.
11. Enari M, Hug H, Nagata S: Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 1995, 375:78-81.
12. Kumar S, Kinoshita M, Noda M, Copeland NG, Jenkins NA: Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene ced-3 and the mammalian IL-1 beta-converting enzyme. Genes Dev 1994, 8:1613-1626.
13. Fernandes Alnemri T, Litwack G, Alnemri ES: CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J Biol Chem 1994, 269:30761-30764.
14. Wang L, Miura M, Bergeron L, Zhu H, Yuan J: Ich-1, an Ice/ ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell 1994, 78:739-750.
15. Fernandes Alnemri, T, Litwack, G, Alnemri, ES: Mch2, a new member of the apoptotic Ced-3/ Ice cysteine protease gene family. Cancer Res 1995, 55:2737-2742.
16. Kamens J, Paskind M, Hugunin M, Talanian RV, Allen H, Banach D, et al.: Identification and characterization of ICH-2, a novel member of the interleukin-1 beta-converting enzyme family of cysteine proteases. J Biol Chem 1995, 270:15250-15256.
17. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, et al.: Identification and inhibition of the ICE/ CED-3 protease necessary for mammalian apoptosis. Nature 1995, 376:37-43.
18. Tewari M, Quan LT, O'Rourke K, Desnoyers, S Zeng Z, Beidler DR, et al.: Yama/ CPP32 beta, a mammalian homolog of CED3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 1995, 81:801-809.
19. Faucheu C, Diu A, Chan AW, Blanchet AM, Miossec C, Herve F, et al.: A novel human protease similar to the interleukin-1 beta converting enzyme induces apoptosis in transfected cells. EMBO J 1995, 14:1914-1922.
20. Gagliardini V, Fernandez PA, Lee RK, Drexler HC, Rotello RJ, Fishman MC, et al.: Prevention of vertebrate neuronal death by the crmA gene [erratum appears in Science 1994, 264:1388]. Science 1994, 263:826-828.
21. Miura M, Friedlander RM, Yuan J: Tumor necrosis factor-induced apoptosis is mediated by a CrmA-sensitive cell death pathway. Proc Natl Acad Sci USA 1995, 92:8318-8322.
22. Ni R, Tomita Y, Matsuda K, Ichihara A, Ishimura K, Ogasawara J, et al.: Fas-mediated apoptosis in primary cultured mouse hepatocytes. Exp Cell Res 1994, 215:332-337.
23. Rouquet N, Allemand I, Molina T, Bennoun M, Briand P, Joulin V: Fas-dependent apoptosis is impaired by SV40 T-antigen in transgenic liver. Oncogens 1995, 11:1061-1067.
24. Lacronique V, Mignon A, Fabre M, Viollet B, Rouquet N, Molina T, et al.: Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nat Med 1996, 2:80-86.
25. Vassalli P: The pathophysiology of tumor necrosis factors. Annu Rev Immuno 1992, 10:411-452.
26. Lehman V, Freudenberg MA, Galanos C: Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J Exp Med 1987, 165:657-663.
27. Dinarello CA, Gelfand JA, Wolff SM: Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. J Am Med Assoc 1993, 269:1829-1835.
28. Pfeffer K, Matsuyama T, Kündig TM, Wakeham A, Kishihara K, Weigmann K, et al.: Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L monocytogenes infection. Cell 1993, 73:457-467.
29. Li P, Allen H, Banerjee S, Franklin S, Herzog L, Johnston C, et al.: Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell 1995, 80:401-411.